Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 54 citing articles:

Methyltransferase-like proteins in cancer biology and potential therapeutic targeting
Yanan Qi, Zhu Liu, Lian‐Lian Hong, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 55
Latest research progress on anticancer effect of baicalin and its aglycone baicalein
Lin Wang, Ting Feng, Zhilian Su, et al.
Archives of Pharmacal Research (2022) Vol. 45, Iss. 8, pp. 535-557
Closed Access | Times Cited: 43
From Xiaoke to diabetes mellitus: a review of the research progress in traditional Chinese medicine for diabetes mellitus treatment
Xianglong Meng, Xiaoqin Liu, Jiaying Tan, et al.
Chinese Medicine (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 27
Baicalin enhances the chemotherapy sensitivity of oxaliplatin-resistant gastric cancer cells by activating p53-mediated ferroptosis
Lihua Shao, Li Zhu, Rong Su, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 14
Flavonoids and Gastric Cancer Therapy: From Signaling Pathway to Therapeutic Significance
Jiaying Cai, Xiyue Tan, Qichao Hu, et al.
Drug Design Development and Therapy (2024) Vol. Volume 18, pp. 3233-3253
Open Access | Times Cited: 8
The Role of m6A RNA Methylation in Cancer: Implication for Nature Products Anti-Cancer Research
Na Song, Kai Cui, Ke Zhang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 33
HKDC1 upregulation promotes glycolysis and disease progression, and confers chemoresistance onto gastric cancer
Mei‐Qian Wang, Yi‐Ru Chen, Huiwen Xu, et al.
Cancer Science (2022) Vol. 114, Iss. 4, pp. 1365-1377
Open Access | Times Cited: 30
Methyltransferase-like 3 modifications of RNAs: Implications for the pathology in the endocrine system
Xiaojuan Su, Yi Qu, Dezhi Mu
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2024) Vol. 1870, Iss. 3, pp. 167010-167010
Closed Access | Times Cited: 6
The role of m6A and m6Am RNA modifications in the pathogenesis of diabetes mellitus
Daniel Benák, Stepanka Benakova, Lydie Plecitá‐Hlavatá, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 15
Interplay between Phytochemicals and the Colonic Microbiota
Chohee Kwon, Meran Keshawa Ediriweera, Somi Kim Cho
Nutrients (2023) Vol. 15, Iss. 8, pp. 1989-1989
Open Access | Times Cited: 14
Treatment of Intracerebral Hemorrhage with Traditional Chinese Medicine Monomer Wogonin by Modifying NLRP3 with METTL14 to Inhibit Neuronal Cell Pyroptosis
Libo Li, Jinbing Gong, Wenjia Zhang
Applied Biochemistry and Biotechnology (2024)
Closed Access | Times Cited: 5
Key epigenetic enzymes modulated by natural compounds contributes to tumorigenicity
Xiaoyue Zhou, Wanqing Liu, Ziqi Liang, et al.
International Journal of Biological Macromolecules (2025), pp. 140391-140391
Closed Access
Xiaochaihutang ameliorates depression-like behaviors induced via chronic social defeat stress by regulating exon-specific Bdnf transcription through H3K18 acetylation in the hippocampus of mice
Fan Wang, Ziming Li, Boru Li, et al.
Phytomedicine (2025), pp. 156567-156567
Closed Access
Emerging importance of m6A modification in liver cancer and its potential therapeutic role
Tao Chen, Wufei Ye, Songsen Gao, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025), pp. 189299-189299
Closed Access
Discovery of the 2,3-Dihydrobenzopyrane-4-one as a Potent FTO Inhibitor against Obesity-Related Metabolic Diseases
Duo Ma, Xiaowen Liu, Xingxing Zhang, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Resetting the aging clock through epigenetic reprogramming: Insights from natural products
Xin Liu, Jing Feng, Mingli Guo, et al.
Pharmacology & Therapeutics (2025), pp. 108850-108850
Closed Access
Epigenetic effects of herbal medicine
Yu-Yao Wu, Yan‐Ming Xu, Andy T. Y. Lau
Clinical Epigenetics (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 12
METTL3: a multifunctional regulator in diseases
Na Li, Wei Xiang, J.J. Dai, et al.
Molecular and Cellular Biochemistry (2025)
Closed Access
Wogonoside alleviates the proliferation and promotes the apoptosis in liver cancer cells by regulating PI3K/Akt signaling pathway
Xinfang Li, Yitong Huang, Yibo He, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
YTHDC2-mediated m6A mRNA modification of Id3 suppresses cisplatin resistance in non-small cell lung cancer
Xifan Wang, Yu’an Hu, Xiaoqing Li, et al.
Journal of Thoracic Disease (2023) Vol. 15, Iss. 3, pp. 1247-1257
Open Access | Times Cited: 9
Baicalin inhibits hepatocellular carcinoma cell growth and metastasis by suppressing ROCK1 signaling
Jialing Sun, Xuemei Yang, Haitao Sun, et al.
Phytotherapy Research (2023) Vol. 37, Iss. 9, pp. 4117-4132
Closed Access | Times Cited: 9
N6-methyladenosine (m6A) in cancer therapeutic resistance: Potential mechanisms and clinical implications
Dong Wang, Yan Zhang, Qingbo Li, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 167, pp. 115477-115477
Open Access | Times Cited: 9
m6A mRNA methylation: Biological features, mechanisms, and therapeutic potentials in type 2 diabetes mellitus
Yuanyuan Ren, Zi Li, Jiaoyu Li, et al.
Obesity Reviews (2023) Vol. 24, Iss. 12
Closed Access | Times Cited: 9
Alzheimer’s Disease, Obesity, and Type 2 Diabetes: Focus on Common Neuroglial Dysfunctions (Critical Review and New Data on Human Brain and Models)
A. Tolédano, Arantxa Rodríguez‐Casado, María‐Isabel Álvarez, et al.
Brain Sciences (2024) Vol. 14, Iss. 11, pp. 1101-1101
Open Access | Times Cited: 3
Exploration of the potential mechanism of Baicalin for hepatic fibrosis based on network pharmacology, gut microbiota, and experimental validation
Sujie Liu, Pingping Chen, Shadi A. D. Mohammed, et al.
Frontiers in Microbiology (2023) Vol. 13
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top